FREUND CORPORATION – Trademark Portfolio
Entity Type: 03
FREUND CORPORATION holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 15 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include FREUND, SPHEREX, GRANUREX, DILACTOSE, and HI-COATER. The owner is based in Tokyo 169-0072.
1-3-21, Okubo, Shinjuku-ku
Tokyo 169-0072 , JP
Showing of trademarks Trademarks
Trademark Classifications
FREUND CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Machines and machine tools; motors and engines; machine coupling and transmission components
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does FREUND CORPORATION have?
FREUND CORPORATION has 19 U.S. trademarks filed with the USPTO. Of these, 11 registered, 3 abandoned, 4 cancelled.
What trademark classes does FREUND CORPORATION file in?
FREUND CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.
What are FREUND CORPORATION's most well-known trademarks?
FREUND CORPORATION's registered trademark portfolio includes well-known marks such as FREUND, SPHEREX, GRANUREX, DILACTOSE, and HI-COATER. These are among 11 currently registered trademarks in the portfolio.
What is FREUND CORPORATION's trademark registration success rate?
FREUND CORPORATION has a 61% trademark registration rate, with 11 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.